Veterinary Medicines

Colombovac PMV suspension for injection

Authorised
  • Newcastle disease virus, strain La Sota, Inactivated
Download as PDF

Product identification

Medicine name:
Colombovac PMV suspension for injection
Active substance:
  • Newcastle disease virus, strain La Sota, Inactivated
Target species:
  • Pigeon
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Newcastle disease virus, strain La Sota, Inactivated
    19.90
    allergen unit(s)
    /
    0.20
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Pigeon
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01EA01
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Nature: 20ml, Type hydrolytic I glass vial (Ph.Eur.)Closure: Butyl rubber stopper (Ph.Eur.), sealed by 20mm aluminium “tear-off” capContents: 1 x 100 doses (20ml) Colombovac®PMV.
  • Nature: 20ml, Type hydrolytic I glass vial (Ph.Eur.)Closure: Butyl rubber stopper (Ph.Eur.), sealed by 20mm aluminium “tear-off” capContents:1 x 50 doses (10ml) Colombovac®PMV.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10387/007/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 24/08/2025
Download